Michael S. Brown, Director of Regeneron Pharmaceuticals REGN, has filed 0 purchases and 8 sales on the open market. The latest trade was on 01/02.

MB

MB

Michael S. Brown

Director

Company

Regeneron Pharmaceuticals REGN

First filing

23/02/08

Trades

30 trades

Buys / sales

0 / 8

12-month net buying

No record

Last trade

01/02

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
Regeneron PharmaceuticalsREGN	Open-market sale10b5-1 plan	24/06/14	24/06/17	1,535 sh	$1,040.00	$1,596,400	−52.6%
Regeneron PharmaceuticalsREGN	Open-market sale10b5-1 plan	24/05/28	24/05/29	1,172 sh	$974.86	$1,142,535.92	−45.9%
Regeneron PharmaceuticalsREGN	Open-market sale10b5-1 plan	23/12/27	23/12/29	2,049 sh	$898.00	$1,840,002	−62.2%
Regeneron PharmaceuticalsREGN	Open-market sale10b5-1 plan	23/04/21	23/04/24	3,070 sh	$798.42	$2,451,149.4	−71.1%
Regeneron PharmaceuticalsREGN	Open-market sale	23/02/06	23/02/08	3,571 sh2 trades	$797.86avg.	$2,849,158	No record
Regeneron PharmaceuticalsREGN	Open-market sale	23/01/27	23/01/30	1 sh	$747.00	$747	−0.1%
Regeneron PharmaceuticalsREGN	Open-market sale	23/01/06	23/01/10	3,070 sh	$747.14	$2,293,719.8	−71.1%